Microbot Medical to Review Recent Progress During Needham’s Virtual Healthcare Conference

Rhea-AI Summary

Microbot Medical (NASDAQ: MBOT) will present at the Annual Needham Virtual Healthcare Conference on April 12, 2022, at 8:45 AM ET. Harel Gadot, the Chairman, President, and CEO, will discuss the company and its recent progress. This event can be accessed via the 'Investors' section on their website. Microbot Medical focuses on transformational micro-robotic technologies for both natural and artificial lumens in the human body, aiming to improve patient outcomes and accessibility since its founding in 2010.

Positive

• Microbot Medical specializes in innovative micro-robotic technologies.
• The company is presenting at a notable healthcare conference, indicating engagement with investors.

Negative

• The announcement does not include any specific advancements or financial data.
• Potential risks associated with product development are mentioned, highlighting uncertainties.

HINGHAM, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced it will be presenting at the Annual Needham Virtual Healthcare Conference. Harel Gadot, Chairman, President and CEO will provide an overview of the Company and recent progress on Tuesday, April 12^th at 8:45am ET.

The live and archived replays of the presentation may be accessed via the ‘Investors’ section, under ‘Presentation + Resources’ of the Company’s website at www.microbotmedical.com.

About Microbot Medical

Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot’s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).

Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available at http://www.microbotmedical.com.

Safe Harbor

Statements to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects” and “estimates”) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions, risks inherent in the development and/or commercialization of potential products, including LIBERTY and SCS, the outcome of its studies to evaluate LIBERTY, SCS and other existing and future technologies, uncertainty in the results of pre-clinical and clinical trials or regulatory pathways and regulatory approvals, uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading “Risk Factors” in Microbot Medical’s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC’s web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Investor Contact:

Michael Polyviou
EVC Group
mpolyviou@evcgroup.com
732-933-2754

FAQ

What will Microbot Medical present at the Needham Healthcare Conference?

Microbot Medical will present an overview and recent progress at the conference.

When is Microbot Medical's presentation at the Needham Conference?

The presentation is scheduled for April 12, 2022, at 8:45 AM ET.

Where can I watch Microbot Medical's conference presentation?

The presentation will be available in the 'Investors' section on their website.

What technologies does Microbot Medical focus on?

Microbot Medical focuses on micro-robotic technologies for natural and artificial lumens within the human body.

What are the potential risks mentioned in Microbot Medical's press release?

Potential risks include market conditions and uncertainties in product development and regulatory approvals.